‘Miracle’ Weight Loss Drug Ozempic To Enter US Worth Negotiations Inside A Yr, Novo Nordisk CEO Says Forward Of Senate Listening to – Novo Nordisk (NYSE:NVO)
Novo Nordisk's NVO CEO Lars Fruergaard Jorgensen, has revealed that their diabetes medicine and infrequently hailed as a “miracle” weight ...
